- Home
- REKR vs VANI Comparison
REKR vs VANI Comparison
Compare REKR & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REKR | VANI |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5M | 95.8M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | REKR | VANI |
|---|---|---|
| Price | $0.80 | $1.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 3.1M | 289.4K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.35 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,234,000.00 | $4,000,000.00 |
| Revenue This Year | $12.51 | N/A |
| Revenue Next Year | $23.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $0.92 |
| 52 Week High | $3.42 | $1.92 |
Technical Indicators
Market Signals| Indicator | REKR | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 42.82 | 42.97 |
| Support Level | $0.75 | $1.08 |
| Resistance Level | $0.96 | $1.55 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 8.57 | 11.08 |
Price Performance
Historical ComparisonAbout REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.